The genetics of alzheimer's disease

Progress in Neurobiology

Volumn 52, Issue 6, 1997, Pages 447-454

  Rubinsztein, David C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID PRECURSOR PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ALZHEIMER DISEASE; DEMENTIA; EARLY DIAGNOSIS; GENE LOCUS; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; DEMENTIA; GENOTYPE; HUMANS; MEMBRANE PROTEINS; PRESENILIN-1;

EID: 0030774535     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(97)00014-2     Document Type: Review

References (82)

1. Albert, S. M., Gurland, B., Maestre, G., Jacobs, D. M., Stern, Y. and Mayeux, R. (1995) APOE genotype influences functional status among elderly without dementia. Am. J. Med. Genet. 60, 583-587.
2. Alberts, M. J., Graffagnini, C., McClenny, C., DeLong, D., Strittmatter, W., Saunders, A. M. and Roses, A. D. (1995) ApoE genotype and survival from intracerebral haemorrhage. Lancet 346, 575.
3. Alzheimer's Disease Collaborative Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet. 11, 219-222.
4. Arinami, T., Takekoshi, K., Yanagi, H., Hamamoto, M. and Hamaguchi, H. (1996) The 5 repeat allele in the very low density lipoprotein receptor gene is not increased in sporadic Alzheimer's disease in Japanese. Neurology 47, 1349-1350.
5. Asada, T., Yamagata, Z., Kinoshita, T., Kariya, T., Asaka, A. and Kahuma, T. (1996) Prevalence of dementia and distribution of apo E alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J. Am. Geriatr. Soc. 44, 151-155.
6. Benjamin, R., Leake, A., McArthur, F. K., Ince, P. G., Candy, J. M., Edwardson, J. A., Morris, C. M. and Bjertness, E. (1994) Protective effect of apo E epsilon 2 in Alzheimer's disease. Lancet 344, 473.
7. Chartier-Harlin, M. C., Parfitt, M., Legrain, S., Perez-Tur, J., Brousseau, T., Evans, A., Berr, C., Vidal, O., Roques, P., Gourlet, V., Fruchart, J.-C., Delacourte, A., Rossor, M. and Amouyel, P. (1994) Apolipoprotein E, ∈4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. Molec. Genet. 3, 569-574.
8. Corder, E. H. and Roses, A. D. (1996) No increased risk of the apolipoprotein E ∈2 allele with early-onset Alzheimer's disease. Ann. Neurol. 39, 414-415.
9. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L. and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
10. Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Small, G. W., Roses, A. D., Haines, J. L. and Pericak-Vance, M. A. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7, 180-184.
11. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. M., Perez-Tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M. N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J. and Younkin, S. (1996) Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
12. Haan, J., van Broekhoven, C., van Duijn, C., Voorhoeve, E., Harskamp, F., van Swieten, J. C., Maat-Schieman, M. L., Roos, R. A. C. and Bakker, E. (1994) The apolipoprotein E ∈4 allele does not influence the clinical expression of the amyloid precursor gene codon 693 or 692 mutations. Ann. Neurol. 36, 434-437.
13. Haines, J. L., Pritchard, M. L., Saunders, A. M., Schildkraut, J. M., Growdon, J. H., Gaskell, P. C., Farrer, L. A., Auerbach, S. A., Gusella, J. F., Locke, P. A., Rosi, B. L., Yamaoka, L., Small, G. W., Conneally, P. M., Roses, A. D. and Pericak-Vance, M. A. (1996) No genetic effect of αl-antichymotrypsin in Alzheimer's disease. Genomics 33, 53-56.
14. Hanlon, C. S. and Rubinsztein, D. C. (1995) Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis 112, 85-90.
15. Hardy, J. (1996) Molecular genetics of Alzheimer's disease. Acta Neurol. Scand. (Suppl.) 165, 13-17.
16. Hardy, J., Crook, R., Perry, R., Raghavan, R. and Roberts, G. (1994) ApoE genotype and Down's syndrome. Lancet 343, 979-980.
17. Heston, L. L. (1992) Alzheimer's disease. In: The Genetic Basis of Common Diseases, pp. 792-800. Eds R. A. King, J. I. Rotter and A. G. Motulsky. Oxford University Press: Oxford.
18. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
19. Hutchin, T. and Cortopassi, G. (1995) A mitochondrial clone is associated with increased risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 92, 6892-6895.
20. Hyman, B. T., West, H. L., Rebeck, G. W., Lai, F. and Mann, D. M. (1995) Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Archives of Neurology 52, 373-378.
21. Kakulas, B. A., Wilton, S. D., Fabian, V. A. and Jones, T. M. (1996) Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet 348, 483.
22. Kamboh, M. I., Sanghera, D. K., Ferrell, R. E. and DeKosky, S. T. (1995) APOEz.ast;4-associated Alzheimer's disease risk is modified by αl-antichymotrypsin polymorphism. Nature Genet. 10, 486-488.
23. Kovacs, D. M., Fausett, H. J., Page, K. J., Kim, T.-W., Moir, R. D., Merriam, D. E., Hollister, R. D., Hallmark, O. G., Mancini, R., Felsenstein, K. M., Hyman, B. T., Tanzi, R. and Wasco, W. (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localisation to intracellular membranes in mammalian cells. Nature Med. 2, 224-229.
24. Levitan, D. and Greenwald, I. (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans SI82 Alzheimer's disease gene. Nature 377, 351-354.
25. Levy-Lahad, E., Wasco, W. W., Poorkaj, P., Romano, D., Oshima, J., Pettingell, W. H., Yu, C.-e., Jondro, P. D., Schmidt, S. D., Wang, K., Crowley, A. C., Fu, Y.-H., Guenette, S. Y., Galas, D., Nemens, E., Wijsman, E. M., Bird, T. D., Schellenberg, G. D. and Tanzi, R. E. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
26. Maestre, G., Ottman, R., Stern, Y., Gurland, B., Chun, M., Tang, M. X., Shelanski, M., Tycko, B. and Mayeux, R. (1995) Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann. Neurol. 37, 254-259.
27. Mahley, R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
28. Mann, D. M. A., Pickering-Brown, S. M., Siddons, M. A., Iwatsubo, T., Ihara, Y., Asami-Odaka, A. and Suzuki, N. (1995) The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype. Neurosci. Lett. 196, 105-108.
29. Mattson, M. P. (1996) Untangling the pathophysiochemistry of β-amyloid. Nature Struct. Biol. 2, 926-928.
30. Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M. X., Maestre, G., Ngai, C., Tycko, B. and Ginsberg, H. (1993) The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34, 752-754.
31. Nicoll, J. A., Roberts, G. W. and Graham, D. I. (1996) Amyloid beta-protein, APOE genotype and head injury. Ann. NY Acad. Sci. 777, 271-275.
32. Okuizumi, K., Onodera, O., Namba, Y., Ikeda, K., Yamamoto, T., Seki, K., Ueki, A., Nanko, S., Tanaka, H., Takahaki, H., Oyanagi, K., Mizusawa, H., Kanazawa, I. and Tsuji, S. (1995) Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genet. 11, 207-209.
33. Okuizumi, K., Onodera, O., Seki, K., Tanaka, H., Namba, Y., Ikeda, K., Saunders, A. M., Pericak-Vance, M. A., Roses, A. D. and Tsuji, S. (1996) Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann. Neurol. 40, 251-254.
34. Osuntokun, B. O., Sahota, A., Ogunniyi, A. O., Gureje, O., Baiyewu, O., Adeyinka, A., Oluwole, S. O., Komolafe, O., Hall, K. S., Unverzagt, F. W., Hui, S. L., Yang, M. and Hendrie, H. C. (1995) Lack of an association between apolipoprotein E ∈4 and Alzheimer's disease in elderly Nigerians. Ann. Neurol. 38, 463-465.
35. Payami, H., Zareparsi, S., Montee, K. R., Sexton, G. J., Kaye, J. A., Bird, T. D., Yu, C.-E., Wijsman, E. M., Heston, L. L., Litt, M. and Schellenberg, G. D. (1996) Gender difference in apolipoprotein E-associated risk for familial Alzheimer's disease: a possible clue to the higher incidence of Alzheimer's disease in women. Am. J. Hum. Genet. 58, 803-811.
36. Perez-Tur, J., Wavrant-De Vrieze, F., Lambert, J. C., Chartier-Harlin, M. C. and the Alzheimer's Study Group (1996) Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347, 1561.
37. Pericak-Vance, M. A., Bebout, J. L., Gaskell, P. C., Yamaoka, L. A., Hung, W.-Y., Alberts, M. J., Walker, A. P., Bartlett, R. J., Haynes, C. A., Welsh, K. A., Earl, N. J., Heyman, A., Clark, C. M. and Roses, A. D. (1991) Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48, 1034-1472.
38. Pericak-Vance, M. A., Johnson, C. C., Rimmler, J. B., Saunders, A. M., Robinson, L. C., D'Hondt, E. G., Jackson, C. E. and Haines, J. L. (1996) Alzheimer's disease and apolipoprotein E-4 allele in an Amish population. Ann. Neurol. 39, 700-704.
39. Querfurth, H. W., Wijsman, E. M., St. George-Hyslop, P. H. and Selkoe, D. J. (1995) Beta APP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Brain Res. Mol. Brain Res. 28, 319-337.
40. Raiha, I., Kaprio, J., Koskenvuo, M., Rajal, T. and Sourander, L. (1996) Alzheimer's disease in Finnish twins. Lancet 347, 573-578.
41. Rao, V. S., Cupples, L. A., van Duijn, C. M., Kurz, A., Green, R. C., Chui, H., Duara, R., Auerbach, S. A., Volicer, L., Wells, J., van Broekhoven, C., Growdon, J. H., Haines, J. L. and Farrer, L. A. (1996) Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E ∈4. Am. J. Hum. Genet. 59, 664-675.
42. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human diseases. Science 273, 1516-1517.
43. Rogaev, E. I., Sherrington, R., Rogaeva, E. M., Levesque, G., Ikeda, M., Liang, Y., Chi, H. J., Lin, C., Holman, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Placentini, S., Amaducci, L., Chumakov, L., Cohen, D., Lannfelt, L., Fraser, P. E., Rommens, J. M. and St. George-Hyslop, P. H. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
44. Roses, A. D. (1996) The Alzheimer diseases. Curr. Opin. Neurobiol. 6, 644-650.
45. Roses, A. D., Devlin, B., Conneally, P. M., Small, G. W., Saunders, A. M., Pritchard, M., Locke, P. A., Haines, J. L., Pericak-Vance, M. A. and Risch, N. (1995) Measuring the genetic contribution of APOE in late-onset Alzheimer disease. Am. J. Hum. Genet. (Suppl.) 57, A202.
46. Royston, M. C., Mann, D., Pickering-Brown, S., Owen, F., Perry, R., Raghavan, R., Khin-Nu, C., Tyrer, S., Day, K., Crook, R., Hardy, J. and Roberts, G. W. (1994) Apolipoprotein E∈2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuro Report 5, 2583-2585.
47. Rubinsztein, D. C. (1995) Apolipoprotein E; a review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer's disease. Psychol. Med. 25, 223-229.
48. Rubinsztein, D. C. (1997) A review of the contribution of apo E genotypes to Alzheimer's disease risk and meta-analysis of apo E associations with other neuro-psychiatric disorders. Nutr. Metab. Cardiovasc. Dis. (in press).
49. Rubinsztein, D. C., Hanlon, C. S., Irving, R. M., Goodburn, S., Evans, D. G., Kellar-Wood, H., Xuereb, J., Bandmann, O. and Harding, A. E. (1994) Apo E genotypes in multiple sclerosis, Parkinson's disease, Schwannomas and late-onset Alzheimer's disease. Mol. Cell. Probes 8, 519-525.
50. St George-Hyslop, P., Crapper-McLachlan, D., Tuda, T., Rogaev, E., Karlinsky, H., Lippa, C. F. and Pollen, D. (1994) Alzheimer's disease and possible gene interaction. Science 263, 537.
51. Sandbrink, R., Hartmann, T., Masters, C. L. and Beyreuther, K. (1996) Genes contributing to Alzheimer's disease. Mol. Psychiat. 1, 27-40.
52. Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hullette, C., Crain, B., Goldgaber, D. and Roses, A. D. (1993a) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1462-1472.
53. Saunders, A. M., Schmader, K., Breitner, J. C. S., Benson, M. D., Brown, W. T., Goldfarb, L., Goldgaber, D., Manwaring, M. G., Szymanski, M. H., McKown, N., Dole, K. C., Schmechel, D. E., Strittmatter, W. J., Pericak-Vance, M. A. and Roses, A. D. (1993b) Apolipoprotein E∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342, 710-711.
54. Saunders, A. M., Hulette, C., Welsh-Bohmer, K. A., Schmechel, D. E., Crain, B., Burke, J. R., Alberts, M. J., Strittmatter, W. J., Breitner, J. C. S., Rosenberg, C., Scott, S. V., Gaskell, P. C. Jr., Pericak-Vance, M. A. and Roses, A. D. (1996) Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 348, 90-93.
55. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Vitanen, M., Peskin, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasko, W., Lannfelt, L., Selkoe, D. and Younkin, S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870.
56. Schupf, N., Kapell, D., Lee, J. H., Zigman, W., Canto, B., Tycko, B. and Mayeux, R. (1996) Onset of dementia is associated with apolipoprotein E ∈4 in Down's syndrome. Ann. Neurol. 40, 799-801.
57. Scott, W. K., Growdon, J. H., Roses, A. D., Haines, J. L. and Pericak-Vance, M. A. (1996) Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347, 1186-1187.
58. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., Montes, M. P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. J., Wasko, W., Da Silva, H. A. R., Haines, J. L., Pericak-Vance, M. A., Tanzi, R., Roses, A. D., Frazer, P. E., Rommens, J. M. and St. George-Hyslop, P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
59. Shoffner, J. M., Brown, M. D., Torroni, A., Lott, M. T., Cabell, M. F., Mirra, S. S., Flint Beal, M., Yang, C.-C., Gearing, M., Salvo, R., Watts, R. L., Juncos, J. L., Hansen, L. A., Crain, B. J., Fayad, M., Reckord, C. L. and Wallace, D. C. (1993) Mitochondrial variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17, 171-184.
60. Smith, A. D., Johnston, C., Sim, E., Nagy, Z., Jobst, K. A., Hindley, N. and King, E. (1994) Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA). Lancet 344, 473-474.
61. Smith, A. D., Jobst, K. A., Johnston, C., Joachim, C. and Nagy, Z. (1996) Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet 348, 483-484.
62. Sobel, E., Louhija, J., Sulkava, R., Davanipour, Z., Kontula, K., Miettinen, H., Tikkanen, M., Kainulainen, K. and Tivlis, R. (1995) Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 45, 903-907.
63. Soininen, H. S. and Riekkinen, P. J. Sr (1996) Apolipoproteir, E. memory and Alzheimer's disease. Trends Neurosci. 19, 224-228.
64. Sorbi, S., Nacmias, B., Forleo, P., Piacentini, S., Latorraca, S. and Amaducci, L. (1995) Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann. Neurol. 38, 124-127.
65. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M. A., Enghild, J., Salvesen, G. S. and Roses, A. D. (1993) Apolipoprotein E-high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natn. Acad. Sci. U.S.A. 90, 1977-1981.
66. Talbot, C., Lendon, C., Craddock, N. C., Shears, S., Morris, J. C. and Goate, A. (1994) Protection against Alzheimer's disease with apo E epsilon 2. Lancet 343, 1432.
67. Tang, M.-X., Maestre, G., Tsai, W.-Y., Liu, X.-H., Feng, L., Chung, W.-Y., Chun, M., Schofield, P., Tycko, B. and Mayeux, R. (1995) Synergistic effects of traumatic head injury and apolipoprotein-∈4 in patients with Alzheimer's disease. Neurology 45, 555-557.
68. The French Alzheimer's Disease Collaborative Study Group (1996) Apolipoprotein E does not affect age at onset in patients with chromosome 14 encoded Alzheimer's disease. J. Med. Genet. 33, 174-175.
69. Gln 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years. J. Med. Genet. 33, 1002-1006.
70. Tysoe, C., Galinsky, D., Robinson, D., Brayne, C., Easton, D. F., Huppert, F. A., Dening, T., Paykel, E. S. and Rubinsztein, D. C. (1997a) Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin converting-enzyme and methylenetetrahydrofolate reductase loci as candidates for dementia. Am. J. Med. Genet. 74, 207-212.
71. Tysoe, C., Whittaker, J., Cairns, N. J., Atkinson, P. F., Harrington, C. R., Xuereb, J., Wilcock, G. and Rubinsztein, D. C. (1997b) Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci. Lett. 222, 68-69.
72. van Broekhoven, C., Backhovens, H., Cruts, M., Martin, J J., Crook, R., Houlden, H. and Hardy, J. (1994) APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci. Lett. 169, 179-180.
73. van Broekhoven, C. (1995) Presenilins and Alzheimer's disease. Nature Genet. 11, 230-232.
74. van Duijn, C. M., de Knijff, P., Wehnert, A., De Voecht, J., Bronzova, J. B., Havekas, L. M., Hofman, A. and Van Broekhoven, C. (1995) The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann. Neurol. 37, 605-610.
75. van Gool, W. A., Evenhuis, H. M., van Duijn, C. M. and Dutch Study Group on Down's Syndrome and Ageing (1996) A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann. Neurol. 38, 225-230.
76. Weidemann, A., Paliga, K., Durrwang, U., Czech, C., Evin, G., Masters, C. L. and Beyreuther, K. (1997) Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein. Nature Medicine 3, 328-332.
77. Weintraub, M. S., Eisenberg, S. and Breslow, J. L. (1987) Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 80, 1571-1577.
78. West, H. L., Rebeck, G. W. and Hyman, B. (1994) Frequency of the apolipoprotein epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci. Lett. 175, 46-48.
79. Wisniewski, T., Morelli, L., Wegiel, J., Levy, E., Wisniewski, H. M. and Frangione, B. (1995) The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Ann. Neurol. 37, 136-137.
80. Wolozin, B., Iwasaki, K., Vito, P., Kelly Ganjei, J., Lacana, E., Sunderland, T., Zhao, B., Kusiak, J. W., Wasco, W. and D'Adamio, L. (1996) Participation of Presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713.
81. Wragg, M. A., Talbot, C. J., Morris, J. C., Lendon, C. L. and Goate, A. M. (1995) No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant. Neurosci. Lett. 201, 107-110.
82. Wragg, M. A., Hutton, M., Talbot, C. and the Alzheimer's Disease Collaborative Group (1996) Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347, 509-512.